Merck Company Description
Merck's medicine bag helps asthmatics breathe easier and allows hypertension patients to relax a little. In addition to blockbuster asthma treatment Singulair, the pharmaceutical company's top sellers include cardiovascular drugs ranging from hypertension fighters Cozaar and Hyzaar to cholesterol combatants Vytorin, Zetia, and Zocor. Merck makes drugs in a broad range of other therapeutic areas as well: Januvia is a therapy for type 2 diabetes, Fosamax fights osteoporosis, and Cosopt and Trusopt treat eye disease. In addition to pharmaceuticals, the company makes childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Merck has agreed to acquire Schering-Plough for $41 billion.
View the Comprehensive Company Description for Merck
The Company Description provides a historical perspective of Merck's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Merck's evolution in the marketplace.
